Nicotine metabolism generally can take area within the liver. For that reason, when nicotine is administered throughout the GI procedure, it undergoes 1st-pass metabolism because of the liver, bringing about a bioavailability of only about 20%. This process inherently decreases the bioavailability of nicotine throughout the procedure and may lead t